Azora Therapeutics, Inc. (DE)
ADILNasdaq United States
Market cap
—
Revenue
—
Not reported
Earnings
-$7.98T
Loss-making
Shares outstanding
2,625,890
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
Azora Therapeutics, Inc. (DE) lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for Azora Therapeutics, Inc. (DE) are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.